Cochrane Abstracts
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PI3K/AKT/mTOR Inhibitors for Advanced or Recurrent Endometrial Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/PI3K_AKT_mTOR_inhibitors_for_advanced_or_recurrent_endometrial_cancer_New. Accessed 07 June 2023.
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/PI3K_AKT_mTOR_inhibitors_for_advanced_or_recurrent_endometrial_cancer_New. Accessed June 7, 2023.
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/PI3K_AKT_mTOR_inhibitors_for_advanced_or_recurrent_endometrial_cancer_New
PI3K/AKT/mTOR Inhibitors for Advanced or Recurrent Endometrial Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/PI3K_AKT_mTOR_inhibitors_for_advanced_or_recurrent_endometrial_cancer_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
ID - 438805
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/PI3K_AKT_mTOR_inhibitors_for_advanced_or_recurrent_endometrial_cancer_New
DB - Evidence Central
DP - Unbound Medicine
ER -
